Is PharmaCyte Biotech (PMCB) stock Halal?

PharmaCyte Biotech is a biotechnology company focused on the development and commercialization of cellular therapies for cancer and diabetes management. Operating within the burgeoning biotech industry, the company's main objective is to harness leading-edge cellular therapy technologies to offer innovative treatment options. A notable feature of Pharmacyte Biotech is its proprietary Cell-in-a-Box technology, which is designed for the targeted delivery of chemotherapy drugs to tumor sites, aiming to enhance treatment efficacy while minimizing adverse effects. For Muslim investors, though, the most pressing question is simpler: is PharmaCyte Biotech a Halal investment?

Is PharmaCyte Biotech Shariah compliant?

Technology companies rarely fail AAOIFI screening on what they sell. Software, hardware and digital services are permissible business activities, so for a company like PharmaCyte Biotech the Shariah question moves to the balance sheet: how much of its market value sits in interest bearing debt, how much of its cash earns Riba in conventional deposits, and whether incidental income from impermissible sources creeps past 5% of revenue. These are exactly the ratios AAOIFI Shariah Standard No. 21 polices, and they move every month with the share price.

Does PharmaCyte Biotech pass the business activity test?

The activity screen is only part of the picture this month: PharmaCyte Biotech currently fails the non-permissible income and interest-bearing investments screens, so the overall verdict is not compliant regardless of the business itself. The watch item for technology names is incidental: cash returns and platform content can carry impermissible elements, which AAOIFI tolerates only below the thresholds.

Is PharmaCyte Biotech's income Halal?

No. PharmaCyte Biotech's income from impermissible sources currently exceeds AAOIFI's 5% revenue ceiling, which makes the stock non-compliant on this screen regardless of the others. The screen is reassessed monthly, so the status can change when new financial statements arrive.

Does PharmaCyte Biotech meet AAOIFI's debt and investment ratio requirements?

Not in full. Interest bearing investments currently exceed the 30% cap, while the other ratio stays within it. One breach is enough to fail the screening; the ratios are reassessed monthly under our Shariah Supervisory Board.

Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.

New to the four screens? Read Why a Halal Stock Screener Matters for Halal Investing